EMINEM: Efficacy of Muscoril In NEck Myofascial Syndromes

Phase 4

Completed

• Conditions: Myofascial Pain Syndromes

• Registration Number: NCT00272532
• Lead Sponsor: Sanofi

Brief Summary

Study objective:

* To demonstrate, in patients with myofascial pain syndrome in cervical region, the degree of efficacy of thiocolchicoside ointment administered to trigger point regions compared with the trigger point injection.

Detailed Description

Not available

Study Timeline

• Study Start: 2005-04
• Study First Submitted: 2006-01-04
• Study First Submitted QC: 2006-01-04
• Study First Posted: 2006-01-06
• Status Verified: 2008-02
• Last Update Submitted: 2008-02-18
• Last Update Posted: 2008-02-20

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 65

Inclusion Criteria

• Submitted to clinic with a complaint of head and neck pain
• Be diagnosed as having myofascial pain syndrome by determining the active trigger points in trapezius and/or interscapular region according to criteria of Simons and Travel
• Have 1 to 8 active trigger point(s)

Exclusion Criteria

• Have evident cervical discopathy and signs of osteoarthritis
• Have bleeding diathesis or using anticoagulant medication which hinders injection
• Have known malignity, being used steroids, have immunodepressive disorders and/or being taken immunodepressive drugs
• Be pregnant or have the possibility of being pregnant or not being used a regular contraceptive method
• Have known allergic reaction against Thiocolchicoside

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Pain relief (Visual Analog Scale and sensitometer) and increase in mobility of neck. Patient and physician satisfaction

Trial Locations

Locations (1)

Sanofi-Aventis; 🇹🇷 Istanbul, Turkey